Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 May 2006

Ashida Shingo, Furihata Mutsuo, Katagiri Toyomasa, Tamura Kenji, Anazawa Yoshio, Yoshioka Hiroki, Miki Tsuneharu, Fujioka Tomoaki, Shuin Taro, Nakamura Yusuke, Nakagawa Hidewaki

Abstract excerpt

PURPOSE: The aim of this study is to identify novel molecular targets for development of novel treatment or diagnostic markers of prostate cancer through genome-wide cDNA microarray analysis of prostate cancer cells purified by laser microdissection. EXPERIMENTAL DESIGN AND RESULTS: Here, we identified molecule interacting with CasL-2 prostate cancer variants (MICAL2-PV), novel splicing variants of MICAL2,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptor Proteins, Signal Transducing
Share to Alternative Splicing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytoskeletal Proteins

Share to Intracellular Signaling Peptides and Proteins

Share to LIM Domain Proteins

Share to Microfilament Proteins

Share to Mixed Function Oxygenases

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 16675569
DOI: 10.1158/1078-0432.CCR-05-1995

Genes

MICAL2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression.PMID 16675569Read ↗

Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2Semantic proximity Read ↗

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancerSemantic proximity Read ↗

Comparative genomic and transcriptomic analyses of LNCaP and C4-2B prostate cancer cell lines.Semantic proximity Read ↗

Increased Expression of SIM2-s Protein Is a Novel Marker of Aggressive Prostate CancerSemantic proximity Read ↗

Hypoexpression and Epigenetic Regulation of Candidate Tumor Suppressor Gene <i>CADM-2</i> in Human Prostate CancerSemantic proximity Read ↗

Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate CancerSemantic proximity Read ↗

A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)Semantic proximity Read ↗

GATA2 as a potential metastasis-driving gene in prostate cancerSemantic proximity Read ↗

RIPK2 Stabilizes c-Myc and is an Actionable Target for Inhibiting Prostate Cancer MetastasisSemantic proximity Read ↗

Myeloid differentiation factor-2/LY96, a new predictive biomarker of metastasis in prostate cancer: Clinical implications as a potential therapeutic targetSemantic proximity Read ↗

CKAP2L, a Crucial Target of miR-326, Promotes Prostate Cancer ProgressionSemantic proximity Read ↗

High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.